Literature DB >> 3536595

Lactate during exercise at extreme altitude.

J B West.   

Abstract

Maximal exercise at extreme altitude results in profound arterial hypoxemia and, presumably, extreme tissue hypoxia. The best evidence available indicates that the resting arterial PO2 on the summit of Mount Everest is about 28 torr and that it falls even further during exercise. Nevertheless, some 10 climbers have now reached the summit without supplementary oxygen. Paradoxically, blood lactate for a given work rate at high altitude in acclimatized subjects is essentially the same as at sea level. Because work capacity decreases markedly with increasing altitude, maximal blood lactate also falls. Extrapolation of available data up to 6300 m indicates that a climber who reaches the Everest summit will have no increase in blood lactate. The cause of the low blood lactate during exercise at extreme altitude is not fully understood. One possibility is depletion of plasma bicarbonate in acclimatized subjects, which reduces buffering and results in large increases in H+ concentration for a given release of lactate. The consequent local fall in pH may inhibit enzymes, e.g., phosphofructokinase (EC 2.7.1.56), in the glycolytic pathway.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3536595

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  16 in total

1.  The re-establishment of the normal blood lactate response to exercise in humans after prolonged acclimatization to altitude.

Authors:  G van Hall; J A Calbet; H Søndergaard; B Saltin
Journal:  J Physiol       Date:  2001-11-01       Impact factor: 5.182

2.  Influence of high altitude on cerebral blood flow and fuel utilization during exercise and recovery.

Authors:  K J Smith; D MacLeod; C K Willie; N C S Lewis; R L Hoiland; K Ikeda; M M Tymko; J Donnelly; T A Day; N MacLeod; S J E Lucas; P N Ainslie
Journal:  J Physiol       Date:  2014-10-31       Impact factor: 5.182

Review 3.  Limiting factors to oxygen transport on Mount Everest 30 years after: a critique of Paolo Cerretelli's contribution to the study of altitude physiology.

Authors:  Guido Ferretti
Journal:  Eur J Appl Physiol       Date:  2003-10-03       Impact factor: 3.078

Review 4.  Mitochondrial function at extreme high altitude.

Authors:  Andrew J Murray; James A Horscroft
Journal:  J Physiol       Date:  2015-06-26       Impact factor: 5.182

5.  Metabolite Responsive Nanoparticle-Protein Complex.

Authors:  Krista R Fruehauf; Tae Il Kim; Edward L Nelson; Joseph P Patterson; Szu-Wen Wang; Kenneth J Shea
Journal:  Biomacromolecules       Date:  2019-06-03       Impact factor: 6.988

Review 6.  Lactate during exercise at high altitude.

Authors:  B Kayser
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

7.  Regulation of human metabolism by hypoxia-inducible factor.

Authors:  Federico Formenti; Dumitru Constantin-Teodosiu; Yaso Emmanuel; Jane Cheeseman; Keith L Dorrington; Lindsay M Edwards; Sandy M Humphreys; Terence R J Lappin; Mary F McMullin; Christopher J McNamara; Wendy Mills; John A Murphy; David F O'Connor; Melanie J Percy; Peter J Ratcliffe; Thomas G Smith; Marilyn Treacy; Keith N Frayn; Paul L Greenhaff; Fredrik Karpe; Kieran Clarke; Peter A Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

Review 8.  Acid-base balance at exercise in normoxia and in chronic hypoxia. Revisiting the "lactate paradox".

Authors:  Paolo Cerretelli; Michele Samaja
Journal:  Eur J Appl Physiol       Date:  2003-09-20       Impact factor: 3.078

9.  The lactate paradox revisited in lowlanders during acclimatization to 4100 m and in high-altitude natives.

Authors:  G van Hall; C Lundby; M Araoz; J A L Calbet; M Sander; B Saltin
Journal:  J Physiol       Date:  2009-01-12       Impact factor: 5.182

10.  Metabolic adaptation of skeletal muscle to high altitude hypoxia: how new technologies could resolve the controversies.

Authors:  Andrew J Murray
Journal:  Genome Med       Date:  2009-12-18       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.